Dilution profile // every instrument, one screen, from SEC filings

Anixa Biosciences Inc (ANIX)

CIK 715446 · all EDGAR filings →

Overall dilution risk
HIGHworst of 4 computed signals (offering ability)
= the worst band among the computed sub-ratings, no hidden weighting
Offering ability
HIGH$200M registered
= total registered offering amount from the fee exhibits of live registrations (bands: $1M / $20M)
registered capacity, not remaining: amounts already taken down are not subtracted yet
Overhead supply
LOWwarrants = 17% of O/S
= warrant shares outstanding divided by current shares outstanding (bands: 20% / 50%)
warrants only; converts, ATMs and equity lines are not in free structured data, so the true overhead is AT LEAST this
Historical dilution
LOW+10% O/S in 3y
= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative
a reverse-split-sized cliff is in this window; read the chart
Cash need
MEDIUM~22.9 months of runway
= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

2020-09-082026-06-10

Latest: 34.0M shares as of Jun 10, 2026 (10-Q). Share count fell from 218.9M to 8.7M between May 18, 2015 and Aug 14, 2015, a pattern consistent with a reverse split (roughly 1-for-25); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.

Cash runway

Funded — but tight

~23 months of cash · watch

Full breakdown: cash runway tool · source filing →

Warrants

Warrants outstanding: 5.9M underlying shares, as reported Jan 25, 2013 (10-Q/A).

Rough fully diluted estimate: 39.9M = 34.0M O/S + 5.9M warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.

Convertible notes

No convertible-note facts tagged in the 10-Q filed Jun 10, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.

Fully diluted build-up

Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.

Shares outstanding34.0MJun 10, 2026
+ Warrants (aggregate, as tagged) (if exercised)5.9MJan 25, 2013
Fully diluted estimate39.9M+17.3% vs O/S

Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.

Registrations and offerings

Registered offering capacity on live registrations: $200.0Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted

S-3Sep 10, 2025$200.0M registeredfiling →

Last 12 months: 0 executed · 1 registered.

EFFECTIVESep 30, 2025SEC declared a registration effective — selling can beginEFFECT
REGISTEREDSep 10, 2025S-3 registration — capacity to sell shares, not a sale yetS-3
EFFECTIVESep 19, 2022SEC declared a registration effective — selling can beginEFFECT
REGISTEREDSep 9, 2022S-3 registration — capacity to sell shares, not a sale yetS-3
EXECUTEDMar 24, 2021Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5
MARKETINGMar 23, 2021Free-writing prospectus — offering being marketedFWP
EXECUTEDMar 22, 2021Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5
MARKETINGMar 22, 2021Free-writing prospectus — offering being marketedFWP
UPDATEJan 9, 2020Prospectus update — often a resale registration, not necessarily new capital424B3
EFFECTIVEJun 21, 2019SEC declared a registration effective — selling can beginEFFECT
REGISTEREDJun 11, 2019S-3 registration — capacity to sell shares, not a sale yetS-3
EXECUTEDMar 27, 2018Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full ANIX workspace